Synthesis and Evaluation of Benzimidazole Derivatives as Selective COX-2 Inhibitors

ISSN: 1875-6638 (Online)
ISSN: 1573-4064 (Print)

Volume 10, 8 Issues, 2014

Download PDF Flyer

Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.387
5 - Year: 1.379

Synthesis and Evaluation of Benzimidazole Derivatives as Selective COX-2 Inhibitors

Author(s): Ankita Rathore, Mujeeb -Ur- Rahman, Anees A. Siddiqui, Abuzer Ali and Mohammad Shahar Yar

Affiliation: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi-110062, India


A new series of 1-{(5-substituted-alkyl/aryl-1,3,4-oxadiazol-2-yl)methyl}-2-(piperidin-1-ylmethyl)-1H-benzimidazoles (5a-5r) was synthesized and screened for their inhibitory activity against COX (1 and 2). In-vivo anti-inflammatory activity of potent compounds was done by carrageenan-induced rat paw edema model. In-vitro anticancer activity of synthesized compounds was also performed at the National Cancer Institute (NCI) against NCI 60 cell lines panel. Out of 18 compounds screened, 5h, 5i, 5j and 5l were found to be potent COX-2 inhibitors in the range of IC50 0.06–0.81 µM. In vivo anti-inflammatory screening results revealed that the compounds 5h and 5j manifested profound percent protection of 72.8 and 75.0%, respectively. Compound 5f exhibited moderate cytotoxicity with 58.79% growth inhibition against SNB-75 (CNS Cancer) cell lines and moderate activity against COX-2 (IC50 = 8.0 µM)

Purchase Online Order Reprints Order Eprints Rights and Permissions


Article Details

Volume: 10
First Page: 1
Page Count: 1
DOI: 10.2174/1573406410666140815121613

Related Journals

Webmaster Contact: Copyright © 2014 Bentham Science